COMPANY WORKBOOK · EW
Edwards Lifesciences Corporation
Healthcare & Life Sciences · Medical Devices
$102.14+1.31%
73/100
INTERACTIVE PRICE CHART
Trend and moving averages
RELATIVE PERFORMANCE
EW versus SPY and SMH
Indexed to 100
Cross-sectional ranking
Scores are percentile-ranked against the current Young Bull universe and stored by date in PostgreSQL.
Healthcare & Life Sciences
This company is available as a market-data workbook. Young Bull has not added a manual investment thesis for it yet.
MODEL READ
Overall score: 72.5. Last ranked 2026-11-07.
QUARTERLY FUNDAMENTALS
Revenue and earnings power
TRAILING P/E59.38
PRICE / SALES8.80
EV / EBITDA26.20
BOOK VALUEN/A
GROSS MARGIN78.0%
PROFIT MARGIN15.3%
RETURN ON EQUITY9.3%
FREE CASH FLOW1.15B
What it does
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
PRIMARY SOURCES